Llovet JM - Search Results

1

Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma.

Montal R, Sia D, Montironi C, Leow WQ, Esteban-Fabró R, Pinyol R, Torres-Martin M, Bassaganyas L, Moeini A, Peix J, Cabellos L, Maeda M, Villacorta-Martin C, Tabrizian P, Rodriguez-Carunchio L, Castellano G, Sempoux C, Minguez B, Pawlik TM, Labgaa I, Roberts LR, Sole M, Fiel MI, Thung S, Fuster J, Roayaie S, Villanueva A, Schwartz M, Llovet JM. Montal R, et al. Among authors: llovet jm. J Hepatol. 2020 Aug;73(2):315-327. doi: 10.1016/j.jhep.2020.03.008. Epub 2020 Mar 12. J Hepatol. 2020. PMID: 32173382 Free PMC article.

2

Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power.

Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, Franca A, Brú C, Navasa M, Ayuso MC, Solé M, Real MI, Vilana R, Rimola A, Visa J, Rodés J. Llovet JM, et al. Hepatology. 1998 Jun;27(6):1572-7. doi: 10.1002/hep.510270616. Hepatology. 1998. PMID: 9620329

3

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.

Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, Brú C, Rodés J, Bruix J. Llovet JM, et al. Hepatology. 1999 Jan;29(1):62-7. doi: 10.1002/hep.510290145. Hepatology. 1999. PMID: 9862851 Clinical Trial.

4

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.

Llovet JM, Fuster J, Bruix J. Llovet JM, et al. Hepatology. 1999 Dec;30(6):1434-40. doi: 10.1002/hep.510300629. Hepatology. 1999. PMID: 10573522

5

Prevalence and prognostic value of hepatocellular carcinoma in cirrhotic patients presenting with spontaneous bacterial peritonitis.

Llovet JM, Moitinho E, Sala M, Bataller R, Rodríguez-Iglesias P, Castells A, Fernández J, Planas R, Navasa M, Bruix J, Rodés J. Llovet JM, et al. J Hepatol. 2000 Sep;33(3):423-9. doi: 10.1016/s0168-8278(00)80278-0. J Hepatol. 2000. PMID: 11019998

6

The current status of liver transplantation for primary hepatic malignancy.

Suarez Y, França AC, Llovet JM, Fuster J, Bruix J. Suarez Y, et al. Among authors: llovet jm. Clin Liver Dis. 2000 Aug;4(3):591-605. doi: 10.1016/s1089-3261(05)70128-8. Clin Liver Dis. 2000. PMID: 11232163 Review.

7

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

Llovet JM, Vilana R, Brú C, Bianchi L, Salmeron JM, Boix L, Ganau S, Sala M, Pagès M, Ayuso C, Solé M, Rodés J, Bruix J; Barcelona Clínic Liver Cancer (BCLC) Group. Llovet JM, et al. Hepatology. 2001 May;33(5):1124-9. doi: 10.1053/jhep.2001.24233. Hepatology. 2001. PMID: 11343240

8

[Liver resection in the treatment of hepatocellular carcinoma].

Llovet JM, Fuster J. Llovet JM, et al. Gastroenterol Hepatol. 2001 Dec;24(10):511-3. Gastroenterol Hepatol. 2001. PMID: 11730622 Spanish. No abstract available.

9

Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation.

Llovet JM, Mas X, Aponte JJ, Fuster J, Navasa M, Christensen E, Rodés J, Bruix J. Llovet JM, et al. Gut. 2002 Jan;50(1):123-8. doi: 10.1136/gut.50.1.123. Gut. 2002. PMID: 11772979 Free PMC article.

10

Prognosis of hepatocellular carcinoma.

Llovet JM, Fuster J, Bruix J. Llovet JM, et al. Hepatogastroenterology. 2002 Jan-Feb;49(43):7-11. Hepatogastroenterology. 2002. PMID: 11941987 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

356 results

Search Page